These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2997384)

  • 21. Zwitterionic detergent solubilisation of HSV-1 surface antigens.
    Jennings R; Quasim T; Sharrard RM; Hockley D; Potter CW
    Arch Virol; 1988; 98(3-4):137-53. PubMed ID: 2831853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of monoclonal antibodies to HSV-1 and HSV-2 for serological analysis of the viral glycoproteins.
    Pereira L
    Dev Biol Stand; 1982; 52():115-31. PubMed ID: 6299824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immunoglobulin response to individual HSV-1 viral polypeptides: kinetics of the response during primary and secondary experimental infection with herpes simplex virus.
    McKendall RR; Pettit M; Woo W
    J Med Microbiol; 1988 Jan; 25(1):59-66. PubMed ID: 2826790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HSV-1 gB and VZV gp-II crossreactive antibodies in human sera.
    Kühn JE; Klaffke K; Munk K; Braun RW
    Arch Virol; 1990; 112(3-4):203-13. PubMed ID: 2165766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody response to herpes simplex virus glycoproteins gB and gD.
    Bernstein DI; Frenkel LM; Bryson YJ; Myers MG
    J Med Virol; 1990 Jan; 30(1):45-9. PubMed ID: 2154542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic-dose acyclovir to suppress frequently recurring genital herpes simplex virus infection: effect on antibody response to herpes simplex virus type 2 proteins.
    Gold D; Ashley R; Solberg G; Abbo H; Corey L
    J Infect Dis; 1988 Dec; 158(6):1227-34. PubMed ID: 2848900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: effects of acyclovir.
    Bernstein DI; Stanberry LR; Harrison CJ; Kappes JC; Myers MG
    J Gen Virol; 1986 Aug; 67 ( Pt 8)():1601-12. PubMed ID: 3016155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dynamics of the formation of antibodies to surface and internal proteins of the herpes simplex virus in a model experiment on rabbits].
    Zvonarev AIu; Cheliapov NV; Ebralidze LK; Malytseva NN
    Biull Eksp Biol Med; 1987 Oct; 104(10):476-8. PubMed ID: 2823927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential immunologic reactivity and processing of glycoproteins gA and gB of herpes simplex virus types 1 and 2 made in Vero and HEp-2 cells.
    Pereira L; Dondero D; Norrild B; Roizman B
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5202-6. PubMed ID: 6272294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes.
    Stanberry LR; Bernstein DI; Burke RL; Pachl C; Myers MG
    J Infect Dis; 1987 May; 155(5):914-20. PubMed ID: 3031173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of herpes simplex virus type 1 glycoproteins interacting with the cell surface.
    Kühn JE; Kramer MD; Willenbacher W; Wieland U; Lorentzen EU; Braun RW
    J Virol; 1990 Jun; 64(6):2491-7. PubMed ID: 2159526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secretory IgA antibody in cervicovaginal secretions from women with genital infection due to herpes simplex virus.
    Merriman H; Woods S; Winter C; Fahnlander A; Corey L
    J Infect Dis; 1984 Apr; 149(4):505-10. PubMed ID: 6327834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody responses in humans to individual proteins of herpes simplex viruses.
    Gilman SC; Docherty JJ; Rawls WE
    Infect Immun; 1981 Dec; 34(3):880-7. PubMed ID: 6277791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Herpes simplex virus (HSV)-specific proliferative and cytotoxic T-cell responses in humans immunized with an HSV type 2 glycoprotein subunit vaccine.
    Zarling JM; Moran PA; Brewer L; Ashley R; Corey L
    J Virol; 1988 Dec; 62(12):4481-5. PubMed ID: 2846864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Envelope and membrane glycoproteins of Herpes simplex virus].
    Ramos-Kuri JM
    Rev Latinoam Microbiol; 1992; 34(1):23-31. PubMed ID: 1345300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2.
    Marsden HS; Buckmaster A; Palfreyman JW; Hope RG; Minson AC
    J Virol; 1984 May; 50(2):547-54. PubMed ID: 6323754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyacrylamide gel electrophoretic analysis of herpes simplex virus type 1 immunoprecipitates obtained by quantitative immunoelectrophoresis in antibody-containing agarose gel.
    Norrild B; Vestergaard BF
    J Virol; 1977 Apr; 22(1):113-7. PubMed ID: 192909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein-specific cervical antibody responses to primary genital herpes simplex virus type 2 infections.
    Ashley RL; Corey L; Dalessio J; Wilson P; Remington M; Barnum G; Trethewey P
    J Infect Dis; 1994 Jul; 170(1):20-6. PubMed ID: 8014499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD.
    Zarling JM; Moran PA; Burke RL; Pachl C; Berman PW; Lasky LA
    J Immunol; 1986 Jun; 136(12):4669-73. PubMed ID: 2423598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.